For the Inventor, By the Inventor

Enter assignee name

Ness Ziona, Israel

Mapi Pharma Ltd.

USPTO Granted Patents = 34

CIPO Patents = 8

EPO Patents = 17

Forward Citations = 59

Loading Chart...

Loading Chart...

11 inventors (with patents filed for the assignee):

Ehud Marom (33 out of 34 patents)

Shai Rubnov (25 out of 25 patents)

Nadav Bleich Kimelman (9 out of 9 patents)

4. Michael Mizhiritskii (9 out of 10 patents)

5. Uri Danon (3 out of 3 patents)

6. Anna Gopin (3 out of 3 patents)

7. Frida Grynspan (2 out of 3 patents)

8. Yoram Sela (2 out of 13 patents)

9. Laura Popper (2 out of 2 patents)

10. Galina Zats (2 out of 2 patents)

11. Susanna Tchilibon (1 out of 6 patents)

34 patents: Sort by Forward Citations

1. 12370233 - Depot systems comprising glatiramer acetate (2025-07-29),

2. 12343371 - Method for suppressing or alleviating primary or secondary progressive multiple sclerosis (PPMS or SPMS) using a sustained release depot formulation comprising glatiramer acetate (2025-07-01),

3. 12251380 - Depot systems comprising cariprazine or salts thereof (2025-03-18),

4. RE50301 - Depot systems comprising glatiramer or pharmacologically acceptable salt thereof (2025-02-18),

5. 12161688 - Treatment of inflammatory bowel disease with long acting glatiramer and adipose-derived stem cells (2024-12-10),

6. 12097292 - Process for preparing microparticles containing glatiramer acetate (2024-09-24),

7. 11931357 - Depot systems comprising Cariprazine or salts thereof (2024-03-19),

8. 11865213 - Semaglutide depot systems and use thereof (2024-01-09),

9. RE49251 - Depot systems comprising glatiramer or pharmacologically acceptable salt thereof (2022-10-17),

10. 11471421 - Process for preparing microparticles containing glatiramer acetate (2022-10-18),

11. 11413311 - Treatment of multiple sclerosis with long acting glatiramer and adipose-derived stem cells (2022-08-16),

12. 11167003 - Methods for suppressing or alleviating primary or secondary progressive multiple sclerosis (PPMS or SPMS) using sustained release glatiramer depot systems (2021-11-09),

13. 11026908 - Extended release dosage forms of pregabalin (2021-06-08),

14. 10493122 - Sublingual delivery of glatiramer acetate (2019-12-03),

15. 10111867 - Process and intermediates for the preparation of perampanel (2018-10-30),

MAPI Pharma Ltd. is a pharmaceutical company specializing in the development and commercialization of novel drug delivery systems. With a focus on improving patient outcomes and convenience, MAPI Pharma offers innovative solutions for various therapeutic areas. Our dedicated team of experts is committed to driving scientific advancements and delivering high-quality medicines to patients worldwide.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

34 Patents

#3 in Ness Ziona

#145 in Israel

#19,028 in the World

Ness Ziona, Israel

Mapi Pharma Ltd.

Forward Citations = 59

11 inventors:

Ehud Marom (33 out of 34 patents)

Shai Rubnov (25 out of 25 patents)

Nadav Bleich Kimelman (9 out of 9 patents)

4. Michael Mizhiritskii (9 out of 10 patents)

5. Uri Danon (3 out of 3 patents)

Please report any incorrect information to support@idiyas.com

Loading…